Vudalimab
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Vudalimab, covering 2025-07-17 to 2026-03-13. Get the full timeline:
Most recent: Clinical Trial Update: Study of Vudalimab or Pembrolizumab in Combination With Chemotherapy as First-line Treatment in Patients With Advanced NSCLC [Phase 1, Phase 2]